Nextgen (NXGN) - Total Liabilities
Based on the latest financial reports, Nextgen (NXGN) has total liabilities worth ILA11.20 Million ILA (≈ $30.02K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Nextgen growing its equity to track the company's year-over-year net asset growth rate.
Nextgen - Total Liabilities Trend (2008–2024)
This chart illustrates how Nextgen's total liabilities have evolved over time, based on quarterly financial data.
Nextgen Competitors by Total Liabilities
The table below lists competitors of Nextgen ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grupo Vasconia S.A.B
MX:VASCONI
|
Mexico | MX$2.18 Billion |
|
Rights and Issues Investment Trust Public Limited Company
LSE:RIII
|
UK | GBX287.00K |
|
Severfield PLC
LSE:SFR
|
UK | GBX203.49 Million |
|
Margaret Lake Diamonds Inc
V:DIA
|
Canada | CA$859.97K |
|
Future Supply Chain Solutions Limited
NSE:FSC
|
India | Rs3.32 Billion |
|
Diaceutics PLC
LSE:DXRX
|
UK | GBX7.18 Million |
|
Ucommune International Ltd
NASDAQ:UK
|
USA | $74.20 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Nextgen's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nextgen market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 7.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nextgen's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nextgen (2008–2024)
The table below shows the annual total liabilities of Nextgen from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA3.04 Million ≈ $8.15K |
+145.16% |
| 2023-12-31 | ILA1.24 Million ≈ $3.32K |
-52.99% |
| 2022-12-31 | ILA2.64 Million ≈ $7.07K |
-9.69% |
| 2021-12-31 | ILA2.92 Million ≈ $7.83K |
+101.17% |
| 2020-12-31 | ILA1.45 Million ≈ $3.89K |
+90.80% |
| 2019-12-31 | ILA761.00K ≈ $2.04K |
+4.25% |
| 2018-12-31 | ILA730.00K ≈ $1.96K |
+5.34% |
| 2017-12-31 | ILA693.00K ≈ $1.86K |
-19.04% |
| 2016-12-31 | ILA856.00K ≈ $2.29K |
+16.46% |
| 2015-12-31 | ILA735.00K ≈ $1.97K |
-82.53% |
| 2014-12-31 | ILA4.21 Million ≈ $11.28K |
+306.96% |
| 2013-12-31 | ILA1.03 Million ≈ $2.77K |
+903.88% |
| 2012-12-31 | ILA103.00K ≈ $276.14 |
-43.09% |
| 2011-12-31 | ILA181.00K ≈ $485.25 |
-64.16% |
| 2010-12-31 | ILA505.00K ≈ $1.35K |
+113.98% |
| 2008-12-31 | ILA236.00K ≈ $632.71 |
-- |
About Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.